Showing results (1241-1250 of 4,560) with videos related to

Sort By:
Pageof 456
Neuropsychiatric Disease and Treatment|September 17, 2021
Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based SurveyJun Ishigooka, Tatsuya Hoshino, Takumi Imai, et al.
Neuropsychiatric Disease and Treatment|August 4, 2022
The Relationship Between Patent Foramen Ovale and Unexplained Dizziness: A Prospective Analysis in ChinaQian Cao, Yu Shen, Zhuo Hou, et al.
Neuropsychiatric Disease and Treatment|September 15, 2021
Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum DisorderChunyang Pan, Yi Zhao, Haojie Xie, et al.
Neuropsychiatric Disease and Treatment|May 22, 2015
The clinical utility of lurasidone in schizophrenia: patient considerationsPhilip D Harvey
Neuropsychiatric Disease and Treatment|May 22, 2015
In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathyNooshin Bazzazi, Mohammad Ahmadpanah, Siamak Akbarzadeh, et al.
Neuropsychiatric Disease and Treatment|May 23, 2015
Profile of agomelatine and its potential in the treatment of generalized anxiety disorderMichelle Nigri Levitan, Marcelo Papelbaum, Antonio Egidio Nardi
Neuropsychiatric Disease and Treatment|May 23, 2015
The cortisol awakening response and major depression: examining the evidenceKatarina Dedovic, Janice Ngiam
Neuropsychiatric Disease and Treatment|May 7, 2015
Comorbid personality disorders among patients with depressionNahathai Wongpakaran, Tinakon Wongpakaran, Vudhichai Boonyanaruthee, et al.
Neuropsychiatric Disease and Treatment|June 2, 2015
The relationship of psychological trauma with trichotillomania and skin pickingEylem Özten, Gökben Hızlı Sayar, Gül Eryılmaz, et al.
Neuropsychiatric Disease and Treatment|April 22, 2015
Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle EastSulaiman Alkhadhari, Nasser Al Zain, Tarek Darwish, et al.
Pageof 456